Stock Details
FRE.DE is Fresenius SE & Co. KGaA's stock. Stock exchange XETRA (Currency EUR). Average price in 50 days is 31.48โ‚ฌ. Average daily volumn in 3 months 1.06M. Market cap 16.05B



Stock symbol : FRE.DE. Exchange : XETRA. Currency : EUR
Lastest price : 28.69โ‚ฌ. Total volume : 367.25k. Market state REGULAR
Click reload if you want to check the lastest price on market!!!

Fresenius SE & Co. KGaA (FRE.DE)
Last Price
28.69โ‚ฌ
Change
-0.63
Volume
367.25k

Previous Close29.32
Open29.45
Day Range28.62-29.49
Bid28.69 x N/A
Ask28.71 x N/A
Volume367.25k
Average Volume1.06M
Market Cap16.05B
Beta1.21
52 Week Range26.52-47.60
Trailing P/E8.94
Foward P/E7.61
Dividend (Yield %)3.16%
Ex-Dividend Date2022-05-16



Financial Details


According to Fresenius SE & Co. KGaA's financial reports the company's revenue in 2021 were 37.52B an increase( +2.78%) over the years 2020 revenue that were of 36.28B. In 2021 the company's total earnings were 1.82B while total earnings in 2020 were 1.71B(0%).


Loading ...



Organization

Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi s... egment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Hรถhe, Germany.

Market Cap:
16.05B
Revenue:
37.52B
Total Assets:
71.96B
Total Cash:
2.76B


News about "Fresenius SE & Co. KGaA"

fresenius-se-co-kgaa-otcmktsfsnuy-given-average-rating-of-hold-by-analysts-image

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Given Average Rating of โ€œHoldโ€ by Analysts

Source from : Defense World - 1 days ago

Shares of Fresenius SE & Co. KGaA (OTCMKTS:FSNUY โ€“ Get Rating) have earned a consensus recommendation of โ€œHoldโ€ from the ten research firms that are covering the company, Marketbeat.com reports. Five ...See details»


equities-analysts-offer-predictions-for-fresenius-se-co-kgaas-fy2022-earnings-otcmktsfsnuy-image

Equities Analysts Offer Predictions for Fresenius SE & Co. KGaAโ€™s FY2022 Earnings (OTCMKTS:FSNUY)

Source from : Defense World - 5 days ago

Other research analysts also recently issued research reports about the stock. Credit Suisse Group upped their price target on shares of Fresenius SE & Co. KGaA from โ‚ฌ35.00 ($37.23) to โ‚ฌ38.00 ($40.43) ...See details»


Fresenius SE & Co. KGaA Expected to Earn FY2026 Earnings of $1.52 Per Share (OTCMKTS:FSNUY)

Source from : ETF Daily News - 6 days ago

Barclays lifted their price objective on shares of Fresenius SE & Co. KGaA from โ‚ฌ50.50 ($53.72) to โ‚ฌ52.50 ($55.85) and gave the company an โ€œoverweightโ€ rating in a research note on Tuesday ...See details»


Fresenius SE & Co KGaA

Source from : Newsweek - 15 days ago

Fresenius SE & Co. KGaA is a European health care company based in Bad Homburg, Germany. The Fresenius Group provides products and services for dialysis, hospitals as well as inpatient and ...See details»


Fresenius SE & Co KGaA - Stock Quote FSNUF

Source from : Morningstar%2c Inc. - 4 days ago

There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...See details»


Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Hits New 52-Week Low at $7.24

Source from : ETF Daily News - 13 days ago

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY โ€“ Get Rating) shares hit a new 52-week low on Tuesday . The stock traded as low as $7.24 and last traded at $7.25, with a volume of 253250 shares. The stock had ...See details»


Fresenius Medical Care AG & Co. KGaA (NYSE: FMS): The Stock For Success Over The Next Few Months

Source from : marketingsentinel - 1 days ago

In the last trading session, 0.38 million Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) shares changed hands as the companyโ€™s beta touched 0. With the companyโ€™s per share price at $25.11 changed ...See details»


DGAP-DD: Fresenius SE & Co. KGaA english

Source from : Business Insider - 25 days ago

Archive at www.dgap.de 75781 10.06.2022 SHARE THIS POST Fresenius NewsMORE Related Stocks Find News News Indices Commodities Currencies Stocks ...See details»


Fresenius Medical Care AG & Co. KGaA

Source from : Wall Street Journal - 6 days ago

Fresenius Medical Care AG & Co. KGaA, Fresenius Management SE, Else Krรถner-Fresenius-Stiftung Dorothea Wenzel Member-Supervisory Board Fresenius Medical Care AG & Co. KGaA, H. Lundbeck A/S ...See details»


Fresenius Medical Care Sale Not Yet Decided, CEO Says

Source from : MarketWatch - 28 days ago

Stephan Sturm, chief executive officer of Fresenius SE & Co. KGaA, said in an interview published on the company's website on Tuesday that a sale of Fresenius Medical Care hasn't been decided.See details»


US General Anesthesia Drugs Market โ€“ Industry Share Analysis, Key Players and Future Prospect

Source from : Digital Journal - 4 days ago

Some of the key players include Baxter International Inc. (US), Hikma Pharmaceuticals plc (UK), Pfizer Inc. (US), Piramal Enterprises Limited (India), AbbVie (US), Fresenius SE & Co. KGaA (Germany ...See details»


Fresenius Weighs Merger of Hospital Arm With Rival Chains

Source from : bnnbloomberg - 6 days ago

German health care conglomerate Fresenius SE is exploring a potential combination of its Helios unit with a rival hospital chain after fielding interest from large buyout funds, people familiar with ...See details»


Fresenius SE & Co. KGaA

Source from : dgap - 26 days ago

Fresenius SE & Co. KGaA: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution Fresenius SE & Co. KGaA / Total Voting Rights ...See details»


DGAP-DD: Fresenius SE & Co. KGaA english

Source from : Business Insider - 25 days ago

Archive at www.dgap.de 75779 10.06.2022 SHARE THIS POST Fresenius NewsMORE Related Stocks Find News News Indices Commodities Currencies Stocks ...See details»